---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001421"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2026-08-27T12:30:31+00:00"
generated_at: "2026-08-27T12:35:10.495107+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences announces 1-for-9 reverse stock split effective Aug 28, 2026

## Summary
- Reverse split ratio 1-for-9, effective 5:00 p.m. ET Aug 28, 2026; split-adjusted trading begins Aug 31, 2026.
- Outstanding shares reduced from 4,929,966 to ~547,774; authorized shares cut from 500M to 55,555,556.
- New CUSIP 04301G805; no fractional shares, each fractional share rounds up to one whole share.
- Warrants and derivatives adjust per terms; shareholder pro-rata ownership unchanged.
- Purpose: improve marketability and liquidity of common stock.

## SEC filing metadata
- accession: 0001640334-26-001421
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2026-08-27T12:30:31+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/0001640334-26-001421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001421
- JSON: https://secwatch.observer/filing/0001640334-26-001421.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001421.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.